1. Home
  2. INVE vs ASRT Comparison

INVE vs ASRT Comparison

Compare INVE & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • ASRT
  • Stock Information
  • Founded
  • INVE 1990
  • ASRT 1995
  • Country
  • INVE United States
  • ASRT United States
  • Employees
  • INVE N/A
  • ASRT N/A
  • Industry
  • INVE Computer peripheral equipment
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • ASRT Health Care
  • Exchange
  • INVE Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • INVE 86.5M
  • ASRT 85.1M
  • IPO Year
  • INVE 1997
  • ASRT 1997
  • Fundamental
  • Price
  • INVE $3.48
  • ASRT $0.80
  • Analyst Decision
  • INVE Strong Buy
  • ASRT Strong Buy
  • Analyst Count
  • INVE 2
  • ASRT 4
  • Target Price
  • INVE $7.25
  • ASRT $3.19
  • AVG Volume (30 Days)
  • INVE 39.5K
  • ASRT 362.1K
  • Earning Date
  • INVE 03-11-2025
  • ASRT 03-10-2025
  • Dividend Yield
  • INVE N/A
  • ASRT N/A
  • EPS Growth
  • INVE N/A
  • ASRT N/A
  • EPS
  • INVE 3.10
  • ASRT N/A
  • Revenue
  • INVE $104,217,000.00
  • ASRT $125,763,000.00
  • Revenue This Year
  • INVE N/A
  • ASRT N/A
  • Revenue Next Year
  • INVE N/A
  • ASRT $1.84
  • P/E Ratio
  • INVE $1.12
  • ASRT N/A
  • Revenue Growth
  • INVE 70.57
  • ASRT N/A
  • 52 Week Low
  • INVE $2.95
  • ASRT $0.73
  • 52 Week High
  • INVE $9.24
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • INVE 43.25
  • ASRT 43.92
  • Support Level
  • INVE $3.50
  • ASRT $0.78
  • Resistance Level
  • INVE $3.82
  • ASRT $0.83
  • Average True Range (ATR)
  • INVE 0.18
  • ASRT 0.03
  • MACD
  • INVE -0.01
  • ASRT 0.00
  • Stochastic Oscillator
  • INVE 21.82
  • ASRT 39.86

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: